Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1 308
1 257 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1 133 |
-2.4%
|
$1.1T |
|
|
|
Johnson & Johnson
JNJ
|
$240.87 |
+1.1%
|
$579.8B |
|
|
|
Roche Holding AG
ROG
|
CHf324.9 |
+4.1%
|
$331.1B |
|
|
|
Merck & Co Inc
MRK
|
$119.05 |
-1.4%
|
$294B |
|
|
|
Novartis AG
NOVN
|
CHf121.8 |
+0.2%
|
$292.6B |
|
|
|
AstraZeneca PLC
AZN
|
GBX13 330 |
-1.8%
|
$277.5B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$45.77 |
+11.1%
|
$239.6B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr286.75 |
+1.5%
|
$197B |
|
|
|
Pfizer Inc
PFE
|
$26.21 |
+0.2%
|
$149.4B |
1 252 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
